Susquehanna International Group, LLP Wave Life Sciences Ltd. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 40,531 shares of WVE stock, worth $438,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,531
Previous 83,400
51.4%
Holding current value
$438,140
Previous $683,000
26.65%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding WVE
# of Institutions
190Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$197 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$104 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$89.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$72.8 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$72.6 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $939M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...